Patents by Inventor Boaz Arzi

Boaz Arzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241338
    Abstract: Provided are methods employing of mesenchymal stem cells (MSCs) to prevent, mitigate and/or reverse oral inflammatory conditions, particularly chronic, recalcitrant, unresponsive and/or persistent oral inflammatory conditions, including chronic gingivostomatitis, in a mammal. Methods for preparation of the MSCs are also provided.
    Type: Application
    Filed: October 11, 2021
    Publication date: August 4, 2022
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Boaz Arzi, Dori L. Borjesson, Frank J.M. Verstraete
  • Publication number: 20210393697
    Abstract: Provided are methods of determining whether a mammalian subject having an inflammatory condition (e.g., an oral inflammatory condition) will respond positively to mesenchymal stem cell (MSC) therapy, as well as method of treating such inflammatory conditions by administering MSCs.
    Type: Application
    Filed: October 5, 2016
    Publication date: December 23, 2021
    Applicant: The Regents of the University of California
    Inventors: Boaz ARZI, Emily Mills KO, Dori L BORJESSON
  • Publication number: 20160199414
    Abstract: Provided are methods employing of mesenchymal stem cells (MSCs) to prevent, mitigate and/or reverse oral inflammatory conditions, particularly chronic, recalcitrant, unresponsive and/or persistent oral inflammatory conditions, including chronic gingivostomatitis, in a mammal. Methods for preparation of the MSCs are also provided.
    Type: Application
    Filed: August 18, 2014
    Publication date: July 14, 2016
    Applicant: The Regents of the University of California
    Inventors: Boaz ARZI, Dori L. BORJESSON, Frank J.M. VERSTRAETE
  • Patent number: 6110971
    Abstract: The present invention provides a pharmaceutical or veterinary composition comprising, a carrier and an active ingredient being a compound of the following formula I: ##STR1## wherein R.sup.1 and R.sup.2 are each independently hydrogen, halogen or methoxy, as well as salts of the compound of formula I.Further provided by the invention is a method of treatment of fungal infection, comprising administering to a patient in need, an effective amount of the compound of said formula I.
    Type: Grant
    Filed: February 4, 1999
    Date of Patent: August 29, 2000
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Yair Ben-Ziony, Boaz Arzi